Technical Analysis for SPHS - Sophiris Bio, Inc.

Grade Last Price % Change Price Change
grade F 0.6811 -3.70% -0.03
SPHS closed down 3.7 percent on Thursday, September 19, 2019, on 2.37 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical SPHS trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -3.70%
New 52 Week Low Weakness -3.70%

Older signals for SPHS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of products for the treatment of urological diseases. Its primary product candidate includes PRX302, which has completed a Phase IIb clinical trial for treatment for the symptoms of benign prostatic hyperplasia, as well as for the treatment of prostate cancer. The company was formerly known as Protox Therapeutics Inc. and changed its name to Sophiris Bio, Inc. in April 2012. Sophiris Bio, Inc. is headquartered in La Jolla, California.
Medicine Biopharmaceutical Medical Specialties Prostate Cancer Urology Benign Prostatic Hyperplasia Treatment Of Prostate Cancer Astellas Pharma Histopathology Hyperplasia Treatment Of Urological Diseases Urological Diseases
Is SPHS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.95
52 Week Low 0.6508
Average Volume 118,155
200-Day Moving Average 1.0049
50-Day Moving Average 0.9174
20-Day Moving Average 0.7914
10-Day Moving Average 0.7453
Average True Range 0.0462
ADX 35.52
+DI 8.2111
-DI 33.8324
Chandelier Exit (Long, 3 ATRs ) 0.9014
Chandelier Exit (Short, 3 ATRs ) 0.7894
Upper Bollinger Band 0.9478
Lower Bollinger Band 0.635
Percent B (%b) 0.15
BandWidth 39.524893
MACD Line -0.0599
MACD Signal Line -0.0543
MACD Histogram -0.0056
Fundamentals Value
Market Cap 20.51 Million
Num Shares 30.1 Million
EPS -0.24
Price-to-Earnings (P/E) Ratio -2.84
Price-to-Sales 0.00
Price-to-Book 4.97
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.77
Resistance 3 (R3) 0.77 0.74 0.76
Resistance 2 (R2) 0.74 0.72 0.74 0.75
Resistance 1 (R1) 0.71 0.70 0.70 0.71 0.75
Pivot Point 0.68 0.68 0.67 0.68 0.68
Support 1 (S1) 0.65 0.66 0.64 0.65 0.62
Support 2 (S2) 0.62 0.64 0.62 0.61
Support 3 (S3) 0.59 0.62 0.61
Support 4 (S4) 0.59